Researchers is significantly improved click here the development of an novel treatment for cardiac amyloidosis, leveraging Attruby. Initial patient information reveals promising benefits for patients suffering from this severe condition. The emphasis underscores BridgeBio's focus to managing critical patient demands in the heart field. Attruby: Br